All In Biotech

Free tool

FAERS Monitor: Lioresal

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020075 or its brand name (Lioresal, Baclofen). Reports on generic versions are filed under their own applications.

Reports

85,287

Serious

56,425

66% of reports

Hospitalization

28,021

Death reported

6,381

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue6,308
  • drug ineffective5,651
  • pain5,558
  • fall5,455
  • nausea4,695
  • headache4,449
  • gait disturbance4,137
  • off label use3,870
  • dizziness3,632
  • urinary tract infection3,527
  • asthenia3,445
  • multiple sclerosis relapse3,424
  • muscle spasms3,280
  • diarrhoea3,162
  • vomiting2,874

Reports by year received

View as table
YearReports
2004646
2005757
2006675
2007795
2008886
20091,033
20101,500
20111,741
20122,516
20133,027
20144,252
20155,157
20167,596
20177,024
20187,705
20196,672
20205,778
20215,486
20225,099
20235,673
20244,226
20254,065
20262,975

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,968,872 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
multiple sclerosis relapseSignal3,42412.912.535,866
gait disturbanceSignal4,1375.45.314,743
urinary tract infectionSignal3,5275.25.011,761
muscle spasmsSignal3,2804.54.38,749
fallSignal5,4554.14.012,738
astheniaSignal3,4452.32.22,471
painSignal5,5582.22.23,905
fatigueSignal6,3082.02.03,278
dizziness3,6321.81.71,317
headache4,4491.81.71,479
vomiting2,8741.51.5504
nausea4,6951.51.4717
diarrhoea3,1621.21.2117
off label use3,8701.11.130
drug ineffective5,6511.11.019

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.